- 英文名称
- Idarubicin
- 分子式
- C26H27NO9
- 分子量
- 497.49
- 中文别名
- 伊达比星; 伊达吡星; 4-去甲氧基柔红霉素; (1S,3S)-3-乙酰-1,2,3,4,6,11-六氢-3,15,12-三羟基-6,11-二氧代-L-丁炔基-3-氨基-2,3,6-三脱氧基-Α-L-来苏糖吡喃己糖苷; (7S,9S)-9-乙酰基-7-(((2R,4S,5S,6S)-4-氨基-5-羟基-6-甲基四氢-2H-吡喃-2-基)氧基)-6,9,11-三羟基-7,8,9,10-四氢并四苯-5,12-酮; 4-demethoxydaunomycin; 4-demethoxydaunorubicin; 4-Demethoxy-daunorubicin; Idamycin; Idarubicinum; Idarubicine; Idarubicina; (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione; (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
- 用途
- 抗肿瘤药，适用于成人急性非淋巴细胞性白血病、急性髓细胞性白血病和儿童急性淋巴细胞性白血病，也可用于霍奇金淋巴瘤及非霍奇金淋巴瘤的慢性进展型、晚期乳腺癌等，具有抑制肿瘤生长、抗乳腺癌的作用，用于急性骨髓性白血病。
